Characteristics | n = 10 |
---|---|
Age, years (mean ± SD) | 61.7 ± 14 (36–92) |
Male | 4 |
Body mass index (kg/m2) | 32.1 ± 3.7 (28.2–40) |
eGFR (mL min−1·1.73 m−2) | 76.3 ± 14.4 (51–90) |
Cardiovascular disease | |
Hypertension | 7 |
Hyperlipidemia | 6 |
Ischemic heart disease | 1 |
Medication for cardiovascular disease | |
ACE inhibitors/ARB | 5 |
Beta-blockers | 2 |
Calcium antagonists | 5 |
Nitrate | 1 |
Diuretics | 0 |
Lipid-lowering drugs | 7 |
Therapy for diabetes | |
Metformin | 5 |
Sulfonylureas | 2 |
Dipetidyl peptidase-4 inhibitors | 7 |
Thiazolidinediones | 0 |
Glucagon-like peptide-1 antagonist | 0 |
Insulin | 2 |